jrnl5547

Publication Venue For

  • Erratum: Association of baseline inflammatory biomarkers with cancer mortality in the REGARDS cohort (Oncotarget (2019) 10 (4857-4867) DOI: 10.18632/oncotarget.27108).  11:758. 2020
  • Pathogenic mutations and overall survival in 3,084 patients with cancer: The Hellenic Cooperative oncology group precision medicine initiative.  11:1-14. 2020
  • Association of baseline inflammatory biomarkers with cancer mortality in the REGARDS cohort.  10:4857-4867. 2019
  • Statins affect human glioblastoma and other cancers through TGF-β inhibition.  10:1716-1728. 2019
  • Global gene expression of histologically normal primary skin cells from BCNS subjects reveals "single-hit" effects that are influenced by rapamycin.  10:1360-1387. 2019
  • Dissecting the role of RNA modification regulatory proteins in melanoma.  10:3745-3759. 2019
  • Editorial plasmacytomas: Many faces of one disease, or many diseases with one face?.  10:257-258. 2019
  • The effects of focal adhesion kinase and platelet-derived growth factor receptor beta inhibition in a patient-derived xenograft model of primary and metastatic Wilms tumor.  10:5534-5548. 2019
  • Correction: PD-L1 expression heterogeneity in non-small cell lung cancer: Evaluation of small biopsies reliability (Oncotarget (2017) 8 (90123-90131) DOI: 10.18632/oncotarget.21485).  9:37077. 2018
  • Integrated landscape of copy number variation and RNA expression associated with nodal metastasis in invasive ductal breast carcinoma.  9:36836-36848. 2018
  • Preclinical characterization of tyrosine kinase inhibitor-based targeted therapies for neuroendocrine thyroid cancer.  9:37662-37675. 2018
  • Revisiting entinostat as an immune-potentiating adjuvant.  9:37278-37279. 2018
  • Irradiation of pediatric glioblastoma cells promotes radioresistance and enhances glioma malignancy via genome-wide transcriptome changes..  9:34122-34131. 2018
  • A small molecule regulator of tissue transglutaminase conformation inhibits the malignant phenotype of cancer cells.  9:34379-34397. 2018
  • Can computer-aided diagnosis assist in the identification of prostate cancer on prostate MRI? A multi-center, multi-reader investigation.  9:33804-33817. 2018
  • DNA Repair Molecular Beacon assay: a platform for real-time functional analysis of cellular DNA repair capacity..  9:31719-31743. 2018
  • PD-L1 expression comparison between primary and relapsed non-small cell lung carcinoma using whole sections and clone SP263.  9:30465-30471. 2018
  • MiR-199a-3p decreases esophageal cancer cell proliferation by targeting p21 activated kinase 4.  9:28391-28407. 2018
  • Identification of radiation responsive genes and transcriptome profiling via complete RNA sequencing in a stable radioresistant U87 glioblastoma model..  9:23532-23542. 2018
  • Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma.  9:22665-22679. 2018
  • Correction: Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer [Oncotarget., 7, (2016) (86803-86815)] 10.18632/oncotarget.13466.  9:19459-19459. 2018
  • Zinc finger protein 598 inhibits cell survival by promoting UV-induced apoptosis.  9. 2018
  • CKS1 expression in melanocytic nevi and melanoma.  9:4173-4187. 2018
  • Pre-diagnostic biomarkers of metabolic dysregulation and cancer mortality.  9:16099-16109. 2018
  • DNA repair deregulation in discrete prostate cancer lesions identified on multi-parametric MRI and targeted by MRI/ultrasound fusion-guided biopsy..  8:68038-68046. 2017
  • Implementation and utilization of the molecular tumor board to guide precision medicine..  8:57845-57854. 2017
  • CDK4/6 inhibition is more active against the glioblastoma proneural subtype..  8:55319-55331. 2017
  • DNA repair deregulation in discrete prostate cancer lesions identified on multi-parametric MRI and targeted by MRI/ultrasound fusion-guided biopsy. 2017
  • BH3 mimetics suppress CXCL12 expression in human malignant peripheral nerve sheath tumor cells..  8:8670-8678. 2017
  • A novel small-molecule arylsulfonamide causes energetic stress and suppresses breast and lung tumor growth and metastasis.  8:99245-99260. 2017
  • Angiostatic actions of capsicodendrin through selective inhibition of VEGFR2-mediated AKT signaling and disregulated autophagy.  8:12675-12685. 2017
  • CDK4/6 inhibition is more active against the glioblastoma proneural subtype.  8:55319-55331. 2017
  • Characterization of urinary extracellular vesicle proteins in muscle-invasive bladder cancer.  8:91199-91208. 2017
  • Combination strategies enhance oncolytic virotherapy.  8:34020-34021. 2017
  • Discovery of novel frizzled-7 inhibitors by targeting the receptor's transmembrane domain.  8:91459-91470. 2017
  • Dysadherin specific drug conjugates for the treatment of thyroid cancers with aggressive phenotypes.  8:24457-24468. 2017
  • Epigenetic modifiers upregulate MHC II and impede ovarian cancer tumor growth.  8:44159-44170. 2017
  • Exacerbation of diabetic cardiac hypertrophy in OVE26 mice by angiotensin II is associated with JNK/c-Jun/miR-221-mediated autophagy inhibition.  8:106661-106671. 2017
  • Functional consequence of the p53 codon 72 polymorphism in colorectal cancer.  8:76574-76586. 2017
  • Gadd45a deficiency accelerates BCR-ABL driven chronic myelogenous leukemia.  8:10809-10821. 2017
  • Genomic regulation of invasion by STAT3 in triple negative breast cancer.  8:8226-8238. 2017
  • Histone deacetylase inhibitor thailandepsin-A activates Notch signaling and suppresses neuroendocrine cancer cell growth in vivo.  8:70828-70840. 2017
  • Hoxa9 and Hoxa10 induce CML myeloid blast crisis development through activation of Myb expression.  8:98853-98864. 2017
  • Identification of cellular genes and pathways important for tumorigenicity of hepatocellular carcinoma cell lines by proteomic profiling.  8:96171-96183. 2017
  • Implementation and utilization of the molecular tumor board to guide precision medicine.  8:57845-57854. 2017
  • Insufficient microwave ablation-induced promotion of distant metastasis is suppressed by β-catenin pathway inhibition in breast cancer.  8:115089-115101. 2017
  • Kinase analysis of penile squamous cell carcinoma on multiple platforms to identify potential therapeutic targets.  8:21710-21718. 2017
  • Kinomic profiling identifies focal adhesion kinase 1 as a therapeutic target in advanced clear cell renal cell carcinoma.  8:29220-29232. 2017
  • Molecular characterization of pro-metastatic functions of β4- integrin in colorectal cancer.  8:92333-92345. 2017
  • Noncalcemic 20-hydroxyvitamin D3 inhibits human melanoma growth in in vitro and in vivo models.  8:9823-9834. 2017
  • Osteoclast proton pump regulator Atp6v1c1 enhances breast cancer growth by activating the mTORC1 pathway and bone metastasis by increasing V-ATPase activity.  8:47675-47690. 2017
  • PD-L1 expression heterogeneity in non-small cell lung cancer: Evaluation of small biopsies reliability.  8:90123-90131. 2017
  • Patient-derived DIPG cells preserve stem-like characteristics and generate orthotopic tumors.  8:76644-76655. 2017
  • Phosphodiesterase 10A is overexpressed in lung tumor cells and inhibitors selectively suppress growth by blocking β-catenin and MAPK signaling.  8:69264-69280. 2017
  • Preclinical PET imaging of glycoprotein non-metastatic melanoma B in triple negative breast cancer: Feasibility of an antibody-based companion diagnostic agent.  8:104303-104314. 2017
  • Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancer.  8:20198-20212. 2017
  • RNA sequencing-based cell proliferation analysis across 19 cancers identifies a subset of proliferation-informative cancers with a common survival signature.  8:38668-38681. 2017
  • RNPC1 enhances progesterone receptor functions by regulating its mRNA stability in breast cancer.  8:16387-16400. 2017
  • Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/p21WAF1/CIP1 and p27KIP1 pathway.  8:17216-17228. 2017
  • Resveratrol induces mitochondria-mediated, caspaseindependent apoptosis in murine prostate cancer cells.  8:20895-20908. 2017
  • Skeletal muscle measures and physical function in older adults with cancer: Sarcopenia or myopenia?.  8:33658-33665. 2017
  • Small G protein Rac GTPases regulate the maintenance of glioblastoma stem-like cells in vitro and in vivo.  8:18031-18049. 2017
  • Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequency.  8:65090-65099. 2017
  • The stem cell/cancer stem cell marker ALDH1A3 regulates the expression of the survival factor tissue transglutaminase, in mesenchymal glioma stem cells.  8:22325-22343. 2017
  • Two new species of betatorqueviruses identified in a human melanoma that metastasized to the brain.  8:105800-105808. 2017
  • miR-125b regulates differentiation and metabolic reprogramming of T cell acute lymphoblastic leukemia by directly targeting A20..  7:78667-78679. 2016
  • Emerging roles and underlying molecular mechanisms of DNAJB6 in cancer.  7:53984-53996. 2016
  • KRASG12 mutant induces the release of the WSTF/NRG3 complex, and contributes to an oncogenic paracrine signaling pathway.  7:53153-53164. 2016
  • ZKSCAN3 promotes bladder cancer cell proliferation, migration, and invasion.  7:53599-53610. 2016
  • Isolation, identification, and characterization of novel nanovesicles.  7:41346-41362. 2016
  • Gene expression in normal-appearing tissue adjacent to prostate cancers are predictive of clinical outcome: Evidence for a biologically meaningful field effect.  7:33855-33865. 2016
  • Targeting of glioblastoma cell lines and glioma stem cells by combined PIM kinase and PI3K-p110a inhibition.  7:33192-33201. 2016
  • Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulation.  7:29901-29915. 2016
  • Cinobufagin inhibits tumor growth by inducing intrinsic apoptosis through AKT signaling pathway in human nonsmall cell lung cancer cells.  7:28935-28946. 2016
  • CLEC4C p.K210del variant causes impaired cell surface transport in plasmacytoid dendritic cells of amyotrophic lateral sclerosis..  7:24942-24949. 2016
  • Loss of SOCS3 in myeloid cells prolongs survival in a syngeneic model of glioma.  7:20621-20635. 2016
  • Novel role of STRAP in progression and metastasis of colorectal cancer through Wnt/β-catenin signaling.  7:16023-16037. 2016
  • Protein phosphatase, Mg2+/Mn2+-dependent 1A controls the innate antiviral and antibacterial response of macrophages during HIV-1 and Mycobacterium tuberculosis infection.  7:15394-15409. 2016
  • An alternatively spliced variant of CXCR3 mediates the metastasis of CD133+ liver cancer cells induced by CXCL9.  7:14405-14414. 2016
  • Cilengitide in newly diagnosed glioblastoma: Biomarker expression and outcome.  7:15018-15032. 2016
  • Development of 89Zr-ontuxizumab for in vivo TEM-1/endosialin PET applications.  7:13082-13092. 2016
  • A role for activated Cdc42 in glioblastoma multiforme invasion.  7:56958-56975. 2016
  • BAI1: From cancer to neurological disease.  7:17288-17289. 2016
  • Correction: Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: Tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients [Oncotarget, 7, 9, (2016), (10433-10447) DOI: 10.18632/oncotarget.7197].  7:60775. 2016
  • Crosstalk between the mitochondrial fission protein, Drp1, and the cell cycle is identified across various cancer types and can impact survival of epithelial ovarian cancer patients.  7:60021-60037. 2016
  • Dysregulated human Tyrosyl-DNA phosphodiesterase I acts as cellular toxin.  7:86660-86674. 2016
  • ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast.  7:80655-80663. 2016
  • Fisetin, a dietary flavonoid, augments the anti-invasive and anti-metastatic potential of sorafenib in melanoma.  7:1227-1241. 2016
  • Frequency of CD4+CD25+Foxp3+ cells in peripheral blood in relation to urinary bladder cancer malignancy indicators before and after surgical removal.  7:11450-11462. 2016
  • HIF-3α1 promotes colorectal tumor cell growth by activation of JAK-STAT3 signaling.  7:11567-11579. 2016
  • Heparanase promotes myeloma progression by inducing mesenchymal features and motility of myeloma cells.  7:11299-11309. 2016
  • Identification of quinazoline compounds as novel potent inhibitors of wnt/β-catenin signaling in colorectal cancer cells.  7:11263-11270. 2016
  • Indoleamine 2,3-dioxygenase regulates anti-tumor immunity in lung cancer by metabolic reprogramming of immune cells in the tumor microenvironment.  7:75407-75424. 2016
  • Inhibition of NADPH oxidase 1 activity and blocking the binding of cytosolic and membrane-bound proteins by honokiol inhibit migratory potential of melanoma cells.  7:7899-7912. 2016
  • Inhibition of endothelial Cdk5 reduces tumor growth by promoting non-productive angiogenesis.  7:6088-6104. 2016
  • Loss of tumor suppressor Merlin results in aberrant activation of Wnt/β-catenin signaling in cancer.  7:17991-18005. 2016
  • Melanin content in melanoma metastases affects the outcome of radiotherapy.  7:17844-17853. 2016
  • MicroRNAs for osteosarcoma in the mouse: A meta-analysis.  7:85650-85674. 2016
  • Niclosamide and its analogs are potent inhibitors of Wnt/ß- catenin, mTOR and STAT3 signaling in ovarian cancer.  7:86803-86815. 2016
  • Overexpression of miR-199a-5p decreases esophageal cancer cell proliferation through repression of mitogen-activated protein kinase kinase kinase-11 (MAP3K11).  7:8756-8770. 2016
  • Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: Tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients.  7:10433-10447. 2016
  • RORβ and RORη expression inversely correlates with human melanoma progression.  7:63261-63282. 2016
  • Recombinant oncolytic poliovirus, PVSRIPO, has potent cytotoxic and innate inflammatory effects, mediating therapy in human breast and prostate cancer xenograft models.  7:79828-79841. 2016
  • SIN3A and SIN3B differentially regulate breast cancer metastasis.  7:78713-78725. 2016
  • Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma.  7:1598-1607. 2016
  • The andean anticancer herbal product BIRM causes destabilization of androgen receptor and induces caspase-8 mediated-apoptosis in prostate cancer.  7:84201-84213. 2016
  • The other face of miR-17-92a cluster, exhibiting tumor suppressor effects in prostate cancer.  7:73739-73753. 2016
  • Toll-like receptor 9 expression is associated with breast cancer sensitivity to the growth inhibitory effects of bisphosphonates in vitro and in vivo.  7:87373-87389. 2016
  • VPO1 mediates oxidation of LDL and formation of foam cells.  7:35500-35511. 2016
  • A novel SAHA-bendamustine hybrid induces apoptosis of leukemia cells.  6:20121-20131. 2015
  • An epigenetic auto-feedback loop regulates TGF-β type II receptor expression and function in NSCLC.  6:33237-33252. 2015
  • CD133 initiates tumors, induces epithelial-mesenchymal transition and increases metastasis in pancreatic cancer.  6:8313-8322. 2015
  • Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancer.  6:25308-25319. 2015
  • Crocetinic acid inhibits hedgehog signaling to inhibit pancreatic cancer stem cells.  6:27661-27673. 2015
  • Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1.  6:1582-1593. 2015
  • DNA double strand break repair defect and sensitivity to poly ADP-ribose polymerase (PARP) inhibition in human papillomavirus 16-positive head and neck squamous cell carcinoma.  6:26995-27007. 2015
  • Differential expression of cell cycle regulators in CDK5-dependent medullary thyroid carcinoma tumorigenesis.  6:12080-12093. 2015
  • ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression.  6:29860-29876. 2015
  • Estrogen receptor (ER) was regulated by RNPC1 stabilizing mRNA in ER positive breast cancer.  6:12264-12278. 2015
  • Evidence for the involvement of sphingosine-1-phosphate in the homing and engraftment of hematopoietic stem cells to bone marrow.  6:18819-18828. 2015
  • Fisetin, a phytochemical, potentiates sorafenib-induced apoptosis and abrogates tumor growth in athymic nude mice implanted with BRAF-mutated melanoma cells.  6:28296-28311. 2015
  • Genome-wide 5-hydroxymethylcytosine modification pattern is a novel epigenetic feature of globozoospermia.  6:6535-6535. 2015
  • Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor.  6:21268-21282. 2015
  • Loss of the N-terminal methyltransferase NRMT1 increases sensitivity to DNA damage and promotes mammary oncogenesis.  6:12248-12263. 2015
  • Loss of tumor suppressive microRNA-31 enhances TRADD/NF-κB signaling in glioblastoma.  6:17805-17816. 2015
  • Mitochondrial oncobioenergetic index: A potential biomarker to predict progression from indolent to aggressive prostate cancer.  6:43065-43080. 2015
  • Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial-to-mesenchymal transition in colon and breast cancers.  6:27763-27777. 2015
  • Nuclear-encoded cytochrome c oxidase subunit 4 regulates BMI1 expression and determines proliferative capacity of high-grade gliomas.  6:4330-4344. 2015
  • Point mutations of the mTOR-RHEB pathway in renal cell carcinoma.  6:17895-17910. 2015
  • Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: A systematic review and meta-analysis.  6:39088-39097. 2015
  • RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model.  6:14766-14776. 2015
  • Role and regulation of coordinately expressed de novo purine biosynthetic enzymes PPAT and PAICS in lung cancer.  6:23445-23461. 2015
  • Shh and p50/Bcl3 signaling crosstalk drives pathogenesis of BCCs in Gorlin syndrome.  6:36789-36814. 2015
  • Streptococcus pneumoniae induces pyroptosis through the regulation of autophagy in murine microglia.  6:44161-44178. 2015
  • The host cell side of latent HIV-1 infection.  6:19920-19921. 2015
  • Breaking Bad: how does a neuronal protein cause neuroendocrine cancer?.  5:5-6. 2014
  • An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urine.  5:5218-5233. 2014
  • Endothelial integrin α3β1 stabilizes carbohydrate-mediated tumor/endothelial cell adhesion and induces macromolecular signaling complex formation at the endothelial cell membrane.  5:1382-1389. 2014
  • Epigenetic inactivation of VGF associated with Urothelial Cell Carcinoma and its potential as a non-invasive biomarker using urine.  5:3350-3361. 2014
  • Estrogen receptor alpha prevents bladder cancer development via INPP4B inhibited Akt pathway in vitro and in vivo.  5:7917-7935. 2014
  • GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis.  5:12151-12165. 2014
  • GSK-3 as potential target for therapeutic irvention in cancer.  5:2881-2911. 2014
  • MicroRNA profiling of novel African American and Caucasian Prostate Cancer cell lines reveals a reciprocal regulatory relationship of miR-152 and DNA methyltranferase 1.  5:3512-3525. 2014
  • Proteasome inhibition reverses hedgehog inhibitor and taxane resistance in ovarian cancer.  5:7065-7080. 2014
  • SapC-DOPS-induced lysosomal cell death synergizes with TMZ in glioblastoma.  5:9703-9709. 2014
  • The miR-124-prolyl hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression.  5:6654-6669. 2014
  • Therapeutic CK2 inhibition attenuates diverse prosurvival signaling cascades and decreases cell viability in human breas cancer cells.  5:6484-6496. 2014
  • Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer.  5:8750-8764. 2014
  • A conspiracy of glioma and endothelial cells to invade the normal brain.  2:1-4. 2011
  • Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers.  2:627-637. 2011
  • Recent advances in anti-angiogenic therapy of cancer.  2:122-134. 2011